Background: Today, the health sector in many countries is facing with severe resource constraints; hence it is absolutely necessary that cost-benefit and cost-effectiveness assessment have a major role in design of health services. The purpose of this study was to evaluate the cost-benefit and effectiveness of cervical cancer screening service (Pap smear test) done by the health centers in Damavand County in 2013.
Methods: This is a descriptive study with cross-sectional method. All data was extracted from existing documents in Damavand health network.
Cost of service screening for doing Pap smear test (manpower costs of performing the service, the cost of transferring samples, water, electricity, telephone and gas) was estimated in all health centers then results, were compared with the incomes of this service.
Results: Screening program coverage was 22.3%, 6.9% and 6.05% in 2011, 2012 and 2013 respectively. All costs and incomes of units performing Pap smear screening test were calculated. Entire costs and incomes of this service during 2013 were respectively 303,009,000 and 11,640,000 RLS equal $12,227 and $496.73. Therefore, the cost-benefit ratio of this screening test was approximately 0.040.
Conclusion: The costs of units performing cervical cancer screening test in Damavand Health Center were much more than this benefit and because of a none-positive Pap smear test in spite of high cost, performing this test in Damavand health centers was not cost effective.
Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, Salmeron Castro J, Hernandez Avila M. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res. 1999 May-Jun; 30(3): 50-240
Saberi F, Sadat Z, Abedzadeh-Kalhorudi M. Factors associated with cervical cancer screening and its barriers among women: Kashan, Iran. Payesh 2012; 70-11:365
Jalilian F, Mirzaei-Alavije M, Emdadi S, Nasirzadeh M, Barati M, Hatamzadeh N. Predicting Factors Related with Pap Smear Results among Women based on Health Belief Model. Journal of Health System Research. 2012;6(7): 34-1226
Enjezab B, Farajkhoda T, Mojahed S, Bokaee M. Barriers and Motivators Related to Cervical and Breast Cancer Screening. JSSU. 2004; 12(3): 84-78
Holakuie-Naeeni K, Chinichian M, Ghazizadeh-Ehsaee M, Sadeghipour H, Rafaee-Sheerpak K. Reasons for the lack of women on the basis of Pap test should be re-treated and re-tested Pap smear. Payesh. 2004;3(2): 7-131
Shadpour K, Jamshidbeigi E. Cost analysis in primary healthcare. first ed. Tehran: Ministryof Health and Medical Education with cooperation UNICEF. 1998
Wanderling D, Gruen R, Black N. Private Health Insurance. In: Introduction to Health Economics, 2004; Open University Press.
Koong Sl,Yen AM, Chen TH. Efficacy and Cost-effectiveness of nationwide cervical screening in Taiwan. J Med Screen 2006;13 Suppl 1:S44-7.
Hernández-Peña P, Lazcano-Ponce EC, Alonso-de Ruiz P, Cruz-Valdez A, Meneses-González F, Hernández-Avila. Cost benefit analysis of the programme for early screening of cervici uterin center. Salud Publica Mex 1997;39(4):379-87.
Wordsworth S, Ryan M, Waugh N. Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme. Cytopathology 2001;12(6): 367-376.
Nokiani-Almassi F, Akbari H, Rezaei M, Madani H, Emami AleAgha M. Cost effectiveness of Pap smear in Kermanshah, Iran. Asian Pacific J cancer Prev 2008,9:107-110.
Deng J, Tan H, Yang T, Huang X, Zhou S. Cost benefit of expanding cervical cancer screening. J cent south univ (Med sci). 2010 May;35(5):470-5.
Vijayarag havan A, Efrusy MB, Mayrand MH, Santas CC, Gogin p. Cost Effectiveness of high risk human Papilloma virus testing for cervical cancer. Can j Public Health 2010;101(3):220-5.
Fscoggins J, Ramsy SD, Jackson JC, Taylor VM. Cost Effectiveness of a programme to promote screening for cervical cancer in the Vietnamese’ American population. Asian PacJ cancer Prev 2010;11(3):717-22.
Zhao FH, Chen JF, Gao XH, Gao LM, Liu QG, Liu ZH, et al. [Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2012 Aug;34(8):632-6. PubMed PMID: 23159002.
Garcia-Garrido AB, Vazquez- Rodriquez JA, Grand –Gonzalez E, Ramos Barron MA. Coverage and Costs of opportunistic screening for cervical cancer in Cantabria(spain). Gac Sanit 2014 Jan-Feb;28(1):14-9.
Jowzi F, Hashemifard T, Morowatisharifabad M, Bashir Z. Factors Associated with Pap Smear Screening Test among Women Aged 15-49 based on Protection Motivation Theory. Hayat. 2013; 19 (1) :29-40
Bahiraie A. The importance of Pap Smear in detecting cervical cancer. Hayat 1999;5(2)
Fylan F. Screening for cervical cancer:a review of womans attitudes, knowledge and behavior.Br Gen Pract 1998;48(433):1509-1514.
Jalalvandi M, Khodadostan M. Knowledge and practice of Married women about Pap smear. Iran Journal of Nursing 2005;18(41):139-144.(persian)
Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. obstet Gynecol 1995;85(6):1017-1021.